Rainbow Childrens Medicare Limited Revenue Breakdown – BSE:RAINBOW
NiveshIQ
NSE: RAINBOW · Healthcare
Rainbow Childrens Medicare Ltd.
₹1,496.70▲ ₹27.20 (+1.85%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on RAINBOW. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Rainbow Childrens Medicare Ltd.
Rainbow Children's Medicare Limited operates a multi-specialty paediatric, obstetrics, and gynaecology hospital chain in India, offering medical and healthcare services to children and women. The company's key revenue drivers include newborn and pediatric intensive care, pediatric multi-specialty services, and pediatric quaternary care, such as multi-organ transplantation. Additionally, it provides women care services under the Birthright brand, comprising perinatal care services and gynecology treatments. In FY26, the company reported a record revenue of ₹1,703 Crore and a net income of ₹278 Crore. The company has a strong competitive position in the Indian healthcare market, with a presence in several key cities. With a focus on expanding its capacity and services, Rainbow Children's Med
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,237 Cr +5.40% | ₹1,455 Cr +17.60% | ₹1,703 Cr +17.10% |
| EBITDA Margin | 33.15% | 32.34% | 34.52% |
| Net Profit | ₹215.00 Cr +1.40% | ₹238.00 Cr +10.70% | ₹283.08 Cr +18.90% |
| EPS | ₹21.17 | ₹23.40 | ₹27.41 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Rainbow Childrens Medicare Ltd is Rated Buy
Rainbow Childrens Medicare schedules Q1FY27 earnings call for July 31
🔒
+ 3 more stories about Rainbow Childrens Medicare Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹460 Cr, PAT ₹80 Cr, EPS ₹7.59, EBITDA margin 32.6%. Growth context: revenue YoY +24.3%, PAT YoY +39.9%, revenue QoQ +3.3%, PAT QoQ +7.8%. Street verdict: beat, revenue surprise +1.7%, PAT surprise +7.2%.
Management commentary points to new capacity addition and capex deployment as the primary near-term growth lever, with e...
FY26 (last completed FY): revenue ₹1, 703 Cr, PAT ₹283 Cr, EBITDA margin 34.5%, EPS ₹27.41. Year-on-year: revenue YoY +1...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for RAINBOW
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track RAINBOW alongside your other holdings
Unlock full RAINBOW research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Rainbow Childrens Medicare Ltd.?
NiveshIQ detects active intelligence signals for Rainbow Childrens Medicare Ltd. (RAINBOW) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Rainbow Childrens Medicare Ltd.?
Rainbow Childrens Medicare Ltd. operates in the Healthcare sector with a market capitalisation of ₹1,321,764.4L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.